Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) fell 5.5% on Tuesday . The company traded as low as $1.93 and last traded at $2.08. 876,216 shares traded hands during trading, an increase of 12% from the average session volume of 784,096 shares. The stock had previously closed at $2.20.
Aditxt Stock Performance
The company has a 50 day simple moving average of $5.96 and a 200-day simple moving average of $47.47.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Aditxt stock. IFP Advisors Inc lifted its holdings in shares of Aditxt, Inc. (NASDAQ:ADTX – Free Report) by 66,926.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 10,054 shares of the company’s stock after purchasing an additional 10,039 shares during the period. IFP Advisors Inc owned about 17.64% of Aditxt worth $45,000 as of its most recent filing with the SEC. 15.54% of the stock is owned by hedge funds and other institutional investors.
Aditxt Company Profile
Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.
Further Reading
- Five stocks we like better than Aditxt
- Compound Interest and Why It Matters When Investing
- 3 Mid-Cap Medical Stocks Outperforming the Market
- What is the Shanghai Stock Exchange Composite Index?
- The Top-Ranked Insider Buys From April by Market Cap
- What is a support level?
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.